Harrow Health, Inc. (HROW) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Harrow Health, Inc. on March 13, 2020. The filing serves to announce the Company's financial results for the fiscal year and quarter ended December 31, 2019. The Company is incorporated in Delaware and trades on The NASDAQ Capital Market under the symbol HROW.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The filing explicitly states that the detailed financial results are contained in the press release (Exhibit 99.1) and the letter to stockholders (Exhibit 99.2), which are furnished but not included in the text of this summary.
Material Changes
The filing text does not provide specific data regarding material changes versus prior periods. It only confirms the issuance of results for the period ended December 31, 2019.
Guidance, Outlook, and Risks
The filing includes standard legal disclaimers regarding the information furnished under Item 2.02. The Company states that the information in this Item, including the exhibits, shall not be deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that Section. Furthermore, the Company does not assume any obligation to update the information contained in the press release or letter to stockholders in the future.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the year and quarter ended December 31, 2019.
- Review Exhibit 99.2 (Letter to Stockholders) for management commentary, strategic outlook, and discussion of material risks.
- Verify the Company's liquidity position and debt obligations as detailed in the full financial statements referenced in the exhibits.
- Confirm any forward-looking guidance provided in the press release, noting the disclaimer that the Company is not obligated to update such information.